Literature DB >> 3759127

C3-independent immune haemolysis: mechanism of membrane attack complex formation.

H Kitamura, M Tsuboi, K Nagaki.   

Abstract

The isolated active complex of C5 and C6, C56, was found to bind to EAC142 in the absence of C3 or C7, and to form a unique intermediate, EAC14256, which is susceptible to lysis by the addition of C7, C8 and C9. Further studies revealed that C56 alone could bind to EAC142 but not to E, EA, EAC1 or EAC4, nor to EAC14 in the absence of C7, that the C56 binding to EAC142 was highly dependent on temperature and on the ionic strength of the buffer, and that the degree of EAC14256 formation from EAC142 and C56 depended on the amount of C2 on EAC142 and on the amount of added C56. These findings suggest that C2 or C42 on EAC142 may be an acceptor for C56. In addition, C56 appears to bind to EAC142 much more efficiently than to unsensitized erythrocytes, even in the presence of C7. Thus, binding of C56 to EAC142 is likely to be an initial step of membrane attack complex formation in C3-independent immune haemolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759127      PMCID: PMC1453153     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.

Authors:  K I Yamamoto; T F Lint; H Gewurz
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

2.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

3.  The separation of nine components and two inactivators of components of complement in humansserum.

Authors:  D H Vroon; D R Schultz; R M Zarco
Journal:  Immunochemistry       Date:  1970-01

4.  The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

Authors:  P J Lachmann; A B Kay; R A Thompson
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

5.  Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.

Authors:  U Rother; G Hänsch; K Rother
Journal:  Z Immunitatsforsch Immunobiol       Date:  1976-08

6.  The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.

Authors:  K I Yamamoto; G Gewurz
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

8.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

9.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  1 in total

1.  Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.

Authors:  H Kitamura; M Tsuboi
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.